Literature DB >> 12941958

Diabetes and the accompanying hyperglycemia impairs cardiomyocyte calcium cycling through increased nuclear O-GlcNAcylation.

Raymond J Clark1, Patrick M McDonough, Eric Swanson, Susanne U Trost, Misa Suzuki, Minoru Fukuda, Wolfgang H Dillmann.   

Abstract

Diabetic cardiomyopathy is characterized by impaired cardiac contractility leading to poor myocardial performance. We investigated the role that the hexosamine pathway, and especially altered nuclear O-Glc-NAcylation, plays in the development of diabetic cardiomyopathy. Incubating neonatal rat cardiomyocytes in high glucose (25 mM) resulted in prolonged calcium transients when compared with myocytes incubated in normal glucose (5.5 mM), which is consistent with delayed myocardial relaxation. High glucose-treated myocytes also exhibited reduced sarcoendoplasmic reticulum Ca(2+)-ATPase 2a (SERCA2a) mRNA and protein expression, decreased SERCA2a promoter activity, and increased O-GlcNAcylation of nuclear proteins compared with myocytes treated with normal glucose. Exposure of myocytes to 8 mM glucosamine or an adenovirus expressing O-GlcNAc-transferase (OGT) resulted in prolonged calcium transient decays and significantly reduced SERCA2a protein levels, whereas treatment with an adenovirus encoding O-GlcNAcase (GCA) resulted in improved calcium transients and SERCA2a protein levels in myocytes exposed to high glucose. Effects of elevated glucose or altered O-GlcNAcylation were also observed on essential transcription factors involved in cardiomyocyte function. High glucose-treated myocytes (with or without OGT adenovirus) exhibited increased levels of O-GlcNAcylated specificity protein 1 compared with control myocytes, whereas infecting high glucose-treated myocytes with GCA adenovirus reduced the degree of specificity protein 1 Glc-NAcylation. Treatment of myocytes with 25 mM glucose, 8 mM glucosamine, or OGT adenovirus also significantly reduced levels of myocytes enhancer factor-2A protein compared with control myocytes, whereas infection with GCA adenovirus resulted in improved myocytes enhancer factor-2 expression. Our results suggest that the hexosamine pathway, and O-GlcNAcylation in particular, is important in impaired cardiac myocyte function and the development of diabetic cardiomyopathy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12941958     DOI: 10.1074/jbc.M303810200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  140 in total

Review 1.  The roles of O-linked β-N-acetylglucosamine in cardiovascular physiology and disease.

Authors:  Natasha E Zachara
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-01-27       Impact factor: 4.733

2.  Protein O-GlcNAcylation: A critical regulator of the cellular response to stress.

Authors:  John C Chatham; Richard B Marchase
Journal:  Curr Signal Transduct Ther       Date:  2010-01

Review 3.  Protein O-GlcNAcylation in diabetes and diabetic complications.

Authors:  Junfeng Ma; Gerald W Hart
Journal:  Expert Rev Proteomics       Date:  2013-08       Impact factor: 3.940

4.  The Role of Nonglycolytic Glucose Metabolism in Myocardial Recovery Upon Mechanical Unloading and Circulatory Support in Chronic Heart Failure.

Authors:  Rachit Badolia; Dinesh K A Ramadurai; E Dale Abel; Peter Ferrin; Iosif Taleb; Thirupura S Shankar; Aspasia Thodou Krokidi; Sutip Navankasattusas; Stephen H McKellar; Michael Yin; Abdallah G Kfoury; Omar Wever-Pinzon; James C Fang; Craig H Selzman; Dipayan Chaudhuri; Jared Rutter; Stavros G Drakos
Journal:  Circulation       Date:  2020-04-30       Impact factor: 29.690

5.  Mechanisms of impaired calcium handling underlying subclinical diastolic dysfunction in diabetes.

Authors:  Véronique A Lacombe; Serge Viatchenko-Karpinski; Dmitry Terentyev; Arun Sridhar; Sitaramesh Emani; John D Bonagura; David S Feldman; Sandor Györke; Cynthia A Carnes
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2007-08-29       Impact factor: 3.619

Review 6.  O-GlcNAc and the cardiovascular system.

Authors:  Sujith Dassanayaka; Steven P Jones
Journal:  Pharmacol Ther       Date:  2013-11-25       Impact factor: 12.310

7.  Increased O-GlcNAc levels during reperfusion lead to improved functional recovery and reduced calpain proteolysis.

Authors:  Jia Liu; Richard B Marchase; John C Chatham
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-06-15       Impact factor: 4.733

Review 8.  The role of O-GlcNAc transferase in regulating the gene transcription of developing and failing hearts.

Authors:  Heidi M Medford; Susan A Marsh
Journal:  Future Cardiol       Date:  2014-11

9.  Pyruvate modifies metabolic flux and nutrient sensing during extracorporeal membrane oxygenation in an immature swine model.

Authors:  Dolena R Ledee; Masaki Kajimoto; Colleen M O'Kelly Priddy; Aaron K Olson; Nancy Isern; Isabelle Robillard-Frayne; Christine Des Rosiers; Michael A Portman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-04-24       Impact factor: 4.733

10.  Role for high-glucose-induced protein O-GlcNAcylation in stimulating cardiac fibroblast collagen synthesis.

Authors:  Hugo Aguilar; Eduardo Fricovsky; Sang Ihm; Magdalena Schimke; Lisandro Maya-Ramos; Nakon Aroonsakool; Guillermo Ceballos; Wolfgang Dillmann; Francisco Villarreal; Israel Ramirez-Sanchez
Journal:  Am J Physiol Cell Physiol       Date:  2014-02-19       Impact factor: 4.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.